Breaking News Instant updates and real-time market news.

TMUS

T-Mobile

$74.93

-0.55 (-0.73%)

, S

Sprint

$6.57

-0.01 (-0.15%)

13:23
06/12/19
06/12
13:23
06/12/19
13:23

Dish, Charter, Altice said to eye assets of T-Mobile and Sprint, Bloomberg says

The cable companies are said to be among the suitors favored by the DOJ for assets that may be divested by Sprint (S) and T-Mobile (TMUS) as a condition of getting their merger approved, said Bloomberg.

TMUS

T-Mobile

$74.93

-0.55 (-0.73%)

S

Sprint

$6.57

-0.01 (-0.15%)

DISH

Dish

$37.64

0.4 (1.07%)

CHTR

Charter

$391.38

-0.2 (-0.05%)

ATUS

Altice USA

$23.67

-0.74 (-3.03%)

  • 13

    Jun

TMUS T-Mobile
$74.93

-0.55 (-0.73%)

05/31/19
JPMS
05/31/19
NO CHANGE
JPMS
Verizon, AT&T selloffs present buying opportunities, says JPMorgan
JPMorgan analyst Philip Cusick believes Amazon.com (AMZN) is unlikely to enter the wireless market via an acquisition of Boost Mobile, as reported last night by Reuters. As a result, he believes the selloffs today in shares of Verizon Communications (VZ) and AT&T (T) present buying opportunities.
05/31/19
OPCO
05/31/19
NO CHANGE
OPCO
Outperform
AT&T, Verizon may trade down on Amazon/Boost Mobile news, says Oppenheimer
Following reports that Amazon (AMZN) is interested in buying Boost Mobile from T-Mobile (TMUS) and Sprint (S), Oppenheimer analyst Timothy Horan tells investors in a research note that he believes a deal would be "highly disruptive" to the industry, but would enable the merger approval for the Sprint-T-Mobile deal. The analyst sees Outperform-rated AT&T (T) and Perform-rated Verizon (VZ) trading down on the news, and Sprint trading higher.
05/22/19
BOFA
05/22/19
UPGRADE
Target $11.4
BOFA
Buy
Ericsson upgraded to Buy on 5G leadership, Huawei pressures at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Tal Liani upgraded Ericsson to Buy from Neutral, citing its 5G leadership and potential for longer-term share gains as well as the U.S. pressures on Huawei, which he thinks may add to Ericsson share gains. Additionally, the T-Mobile (TMUS) and Sprint (S) merger, if approved, may help accelerate the 5G timeline, Liani tells investors. The analyst, who added that he had a bullish visit to Ericsson's headquarters last Friday, raised his price target on the ADRs to $11.40 from $10.40.
05/21/19
COWN
05/21/19
NO CHANGE
COWN
State AGs may challenge Sprint, T-Mobile deal even if DOJ approves, says Cowen
Cowen analyst Paul Gallant said he believes that the Department of Justice is likely to approve T-Mobile's (TMUS) deal to buy Sprint (S) despite the Bloomberg report claiming that the DOJ is leaning against signing off on the agreement, with the main reason for his view being the belief that the White House really cares about beating China in 5G. However, he still sees significant risk at the state AG level, noting that Maryland AG Brian Frosch was quoted by Bloomberg as saying that "consumers are going to suffer in terms of price, in terms of quality, in terms of opportunities." Even if the DOJ approves the deal, state AGs have the authority to challenge and they might, Gallant tells investors.
S Sprint
$6.57

-0.01 (-0.15%)

05/22/19
NWST
05/22/19
DOWNGRADE
NWST
Neutral
Sprint downgraded to Neutral from Buy at New Street
DISH Dish
$37.64

0.4 (1.07%)

06/10/19
JPMS
06/10/19
NO CHANGE
Target $38
JPMS
Overweight
AT&T, Dish satellite video combination would make sense, says JPMorgan
It would make sense for AT&T (T) and Dish (DISH) to combine video operations, nearly two decades after an attempt failed in 2002, JPMorgan analyst Philip Cusick tells investors in a research note after press reports discussed a combination of Dish and DirecTV. The analyst believes the dis-synergies of pulling DirecTV away from AT&T's U-verse "in buying power would be value destructive." The analyst, however, does not think the companies are in discussions today, and he sees both "regulatory and personality issues that would have to be overcome to get to a deal." He reiterates Overweight ratings on AT&T and Dish and notes his price targets of $38 from $40, respectively, reflect no potential deal.
05/20/19
05/20/19
DOWNGRADE

Hold
Dish downgraded to Hold at Pivotal Research
As previously reported, Pivotal Research analyst Jeffrey Wlodarczak downgraded Dish (DISH) to Hold from Buy as it appears that the Sprint (S)/T-Mobile (TMUS) deal will clear regulatory hurdles and given the 22.9M share equity deal with sister company EchoStar (SATS). The likely ultimate approval of the Sprint/T-Mobile deal likely "significantly pushes back the timing" for a potential Dish spectrum deal materially, he contends.
05/20/19
PIVT
05/20/19
DOWNGRADE
PIVT
Hold
Dish downgraded to Hold from Buy at Pivotal Research
05/06/19
05/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sinclair Broadcast (SBGI) upgraded to Buy from Neutral at B. Riley FBR with analyst Barton Crockett saying yhe company's deal to acquire 21 regional sports networks from Disney (DIS) at valuation of $10.6B "looks like a home-run". 2. ImmunoGen (IMGN) upgraded to Buy from Neutral at H.C. Wainwright with analyst Debjit Chattopadhyay seeing 40% downside risk to the stock if the FDA does not consider mirvetuximab to be a clinically meaningful addition to the armametum against ovarian cancer versus a 145% upside potential. 3. Dish (DISH) upgraded to Neutral from Underperform at Credit Suisse with analyst Douglas Mitchelson saying he finds that risk/reward and potential catalysts across wireless and Pay TV are now in balance. 4. Post Holdings (POST) upgraded to Buy from Neutral at Goldman Sachs with analyst Jason English stating he views the recent pullback as a buying opportunity as he thinks transient headwinds were the reason results missed investor expectations in Q2. 5. Dentsply Sirona (XRAY) upgraded to Outperform from Market Perform at Barrington with analyst Michael Petusky saying the company's turnaround is "now on a firm, provable footing". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CHTR Charter
$391.38

-0.2 (-0.05%)

04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).
04/09/19
04/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SAP (SAP) downgraded to Hold from Buy at HSBC and to Neutral from Buy at UBS. 2. American Assets Trust (AAT) downgraded to Sector Weight from Overweight at KeyBanc with analyst Todd Thomas saying the stock has surpassed his previous $45 price target. 3. Ball Corp. (BLL) downgraded to Market Perform from Outperform at BMO Capital with analyst Mark Wilde saying that after an "impressive run," the stock is now trading at the upper end of its peer group range. 4. Charter (CHTR) downgraded to Neutral on valuation at Macquarie with analyst Amy Young saying shares reflect much of the operational and free cash flow potential and further multiple expansion hinges on its ability to set a consistent track record. 5. U.S. Steel (X) downgraded to Underperform from Neutral at Credit Suisse with analyst Curt Woodworth saying after performing deep dive analysis on U.S. Steel Flat Rolled segment, the analyst concludes the step-function rise in unit costs the past several years coupled with loss of automotive share suggests the company is in a weaker competitive position versus peers entering the "Sheet Tsunami" period in the U.S. from 2021-2022. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/09/19
MACQ
04/09/19
DOWNGRADE
MACQ
Neutral
Charter downgraded to Neutral on valuation at Macquarie
Macquarie analyst Amy Young downgraded Charter to Neutral from Outperform as shares have largely reached her price target of $375. Young said shares reflect mush of the operational and free cash flow potential and further multiple expansion hinges on its ability to set a consistent track record.
03/29/19
03/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Hold from Buy at Deutsche Bank with analyst Matt O'Connor saying he sees management and earnings uncertainty after the company announced that CEO and President Tim Sloan will step down effective immediately. 2. RH (RH) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Baker saying he continues to believe in the long-term prospects for RH and acknowledges "that it is one of the few retailers growing sales, margins, profit dollars and earnings." 3. Carlyle Group (CG) downgraded to Neutral from Buy at BofA/Merrill. 4. Comcast (CMCSA) and Charter (CHTR) downgraded to Sector Perform from Outperform at RBC Capital. 5. Mosaic (MOS) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying following Mosaic's analyst day, he feels phosphate fundamentals have weakened in the near term and are unlikely to pick-up significantly "despite the company acting as a swing supplier by curtailing capacity." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ATUS Altice USA
$23.67

-0.74 (-3.03%)

05/21/19
JPMS
05/21/19
NO CHANGE
Target $28
JPMS
Overweight
Russell reconstitution a positive for Altice USA, says JPMorgan
JPMorgan analyst Philip Cusick believes the reconstitution of the Russell 3000 Index and Altice USA being added to the Russell 1000 Index, which becomes effective on June 28, will be a positive for the shares. His firm's strategist estimates that indexer demand will be 16,746,467 shares, or 420.6% of Altice USA's average daily volume for a notional value of $390M. Altice's notional addition is the 355 largest of 2,056 by market cap and accounts for 1.4% of the Russell's total notional increase, Cusick tells investors in a research note. Cusick has an Overweight rating on Altice USA with a $28 price target.
03/27/19
JPMS
03/27/19
NO CHANGE
JPMS
Fundamentals across cable remain strong, says JPMorgan
Sustained household formation and wage growth, along with a pullback in promotional activity at AT&T (T), the main competitor to most multi-service operators, keeps fundamentals across cable strong, JPMorgan analyst Philip Cusick tells investors in a research note. In 2018, the U.S. added ~1.5m households for the second year in a row, "which sets up the wireline video and broadband ecosystems well in 2019," says the analyst. Altice USA (ATUS) and Charter Communications (CHTR) are both on the JPMorgan's Analyst Focus List, and Comcast (CMCSA) is Cusick's favorite mega-cap service provider. The analyst is "wary" of the multiple of Underweight-rated Cable One (CABO), but admits its operational momentum seems strong.
02/26/19
SBSH
02/26/19
NO CHANGE
Target $27
SBSH
Buy
Altice USA shares have 'more room to run,' says Citi
Citi analyst Jason Bazinet raised his price target for Altice USA to $27 from $26 and maintains a Buy rating on the shares. In a research note titled "More Room to Run," the analyst says Altice USA is unique among U.S. cable names because it trades on enterprise value to EBITDA. Wireless entry may be critical for Altice's equity, Bazinet contends. He believes that if the company takes advantage of its "favorable" wireless virtual network operator position and "aggressively" rolls out wireless in 2019, it could lift Altice's sales by 100 basis points while only modestly impacting EBITDA margins.

TODAY'S FREE FLY STORIES

CAT

Caterpillar

$134.37

0.43 (0.32%)

17:46
06/24/19
06/24
17:46
06/24/19
17:46
Hot Stocks
Caterpillar awarded share of $900M Defense Logistics Agency contract »

Caterpillar is sharing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$35.14

0.06 (0.17%)

17:45
06/24/19
06/24
17:45
06/24/19
17:45
Hot Stocks
FB Financial provides update on its exit of wholesale mortgage channels »

FB Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$31.11

-0.99 (-3.08%)

17:44
06/24/19
06/24
17:44
06/24/19
17:44
Hot Stocks
Fluor: Stork consortium awarded four-year agreement by Ecopetrol in Colombia »

Fluor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERYP

Erytech Pharma

$6.69

(0.00%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Erytech Pharma announces strategic collaboration with SQZ Biotechnologies »

ERYTECH Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Lockheed Martin awarded $561.80M Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Syndicate
The Medicines Co. files to sell $150M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHTLY

Metcash

$0.00

(0.00%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Downgrade
Metcash rating change at Goldman Sachs »

Metcash downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

HRS

Harris

$197.28

-0.07 (-0.04%)

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

TMSR

TMSR Holding

$1.67

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Syndicate
Breaking Syndicate news story on TMSR Holding »

TMSR Holding files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:27
06/24/19
06/24
17:27
06/24/19
17:27
Syndicate
Breaking Syndicate news story on The Medicines Co. »

The Medicines Co. files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$33.86

-1.31 (-3.72%)

, HF

HFF Inc.

$45.25

-0.29 (-0.64%)

17:22
06/24/19
06/24
17:22
06/24/19
17:22
Hot Stocks
Xencor to replace HFF Inc. in S&P 600 at open on 7/2 »

Jones Lang LaSalle (JLL)…

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

USNA

Usana

$72.41

-0.58 (-0.79%)

, LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

17:20
06/24/19
06/24
17:20
06/24/19
17:20
Hot Stocks
Usana to replace Fidelity Southern in S&P 600 at open on 7/1 »

Ameris Bancorp (ABCB) is…

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

, AAXN

Axon

$73.22

-0.12 (-0.16%)

17:19
06/24/19
06/24
17:19
06/24/19
17:19
Hot Stocks
Breaking Hot Stocks news story on Mesa Labs, Axon »

Mesa Labs to replace Axon…

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAXN

Axon

$73.22

-0.12 (-0.16%)

, MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Axon, MarketAxess »

Axon to replace…

AAXN

Axon

$73.22

-0.12 (-0.16%)

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
MarketAxess to replace L3 Technologies in S&P 500 at open on 7/1 »

Harris (HRS) is acquiring…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

HRS

Harris

$197.28

-0.07 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.81

-0.0026 (-0.32%)

17:04
06/24/19
06/24
17:04
06/24/19
17:04
Hot Stocks
Vista Gold CFO Jack Engele to retire, Douglas Tobler to succeed »

Vista Gold is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:03
06/24/19
06/24
17:03
06/24/19
17:03
Periodicals
Apple to announce Seattle expansion on Monday, Seattle Times reports »

According to a story by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.00

0.07 (0.47%)

, CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Hot Stocks
HP Enterprise appoints Crowdstrike CEO George Kurtz to Board of Directors »

Hewlett Packard…

HPE

HP Enterprise

$15.00

0.07 (0.47%)

CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

NGM

NGM Biopharmaceuticals

$13.88

0.1 (0.73%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Initiation
NGM Biopharmaceuticals initiated at Stifel »

NGM Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$13.81

-0.27 (-1.92%)

17:00
06/24/19
06/24
17:00
06/24/19
17:00
Hot Stocks
Armistice Capital reports 6.2% passive stake in Vanda Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated at Stifel »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$27.47

-0.73 (-2.59%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Hot Stocks
Park Hotels & Resorts announces sale of three non-core assets for $166M »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$79.64

-1.74 (-2.14%)

16:56
06/24/19
06/24
16:56
06/24/19
16:56
Initiation
Intercept initiated at Stifel »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

16:48
06/24/19
06/24
16:48
06/24/19
16:48
Syndicate
Krystal Biotech files to sell $100M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:40
06/24/19
06/24
16:40
06/24/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Genfit »

Genfit SA (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.